Pharmaceuticals, Biotechnology and Life Sciences
SAN FRANCISCO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DNA?src=hash" target="_blank"gt;#DNAlt;/agt;–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality…
Leading gene therapy company announces $235 million investment to accelerate growth RESEARCH TRIANGLE PARK, N.C.& FORT WORTH, Texas & SAN…
LEXINGTON, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24CNCE&src=ctag" target="_blank"gt;$CNCElt;/agt; lt;a href="https://twitter.com/hashtag/CNCE?src=hash" target="_blank"gt;#CNCElt;/agt;–Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that interim clinical data from its…
DUBLIN–(BUSINESS WIRE)–The “In vivo CRO Market Size, Share & Trends Analysis Report By Product Type, By GLP Type, By Indication…
DUBLIN–(BUSINESS WIRE)–The “Angiotensin Converting Enzyme (ACE) Inhibitor -Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Angiotensin Converting…
Mice fed high-fat diet and treated with Gel-B (GS300 prototype) hydrogel were protected against the development of fatty liver and…
— New Proof-of-Concept Data for Combination of Investigational FXR Agonist Cilofexor and ACC Inhibitor Firsocostat in NASH — FOSTER CITY,…
OSAKA, Japan & AMSTERDAM–(BUSINESS WIRE)–Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President & CEO: Isao Teshirogi, Ph.D.; hereafter “Shionogi”)…
CHENGDU, China–(BUSINESS WIRE)–HitGen Inc. announced today that HitGen Inc. and Kaken Pharmaceutical Co., Ltd. have entered into a license agreement…
MELBOURNE, Australia & SAN FRANCISCO–(BUSINESS WIRE)–Alterity Therapeutics Limited, (formerly Prana Biotechnology Limited) (ASX: PBT, NASDAQ: ATHE) (“Alterity” or “the Company”)…